MacroGenics | MGNX - Ebitda

Prix De L'Action
3.19
Variation Quotidienne
0.01 0.31%
Mensuellement
0.63%
Annuel
86.55%
Q2 Prévisions
3.12




Ebitda Changement Date
AbbVie USD 3.52B 828M 2025-09
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Genmab DKK 186M 291M 2025-12
Geron USD -9.47M 1.92M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
J&J USD 7.19B 2.32B 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck USD 8.39B 1.97B 2025-09
Pfizer USD 6.08B 351M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Xencor USD -51.05M 55.28M 2025-12